Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | MYLK | Q15746 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.97 |
| ▸ | MAPT | P10636 | 3/20 | 0.97 |
| ▸ | GMNN | O75496 | 2/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.74 |
| ▸ | TSHR | P16473 | 3/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.74 |
| ▸ | MTOR | P42345 | 1/20 | 0.74 |
| ▸ | RAB9A | P51151 | 1/20 | 0.74 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29370764 | 0.99 | MAPK1 (1.00) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| Hydrochloric Acid SCHEMBL1848494 | 0.99 | MAPK1 (1.00) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| Hydrochloric Acid SCHEMBL1986979 | 0.97 | CYP3A4 (0.95) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL14207926 | 0.86 | KMT2A (0.76) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL3244492 | 0.85 | CYP3A4 (0.74) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL10719519 | 0.85 | SMN1; SMN2 (0.80) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL16613226 | 0.85 | KMT2A (0.74) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL29351112 | 0.85 | ROCK1 (1.00) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL1271163 | 0.85 | ROCK1 (1.00) | CYP3A4KMT2AMAPK1CYP2D6MYLK | |
| SCHEMBL2908958 | 0.85 | ROCK2 (0.75) | CYP3A4KMT2AMAPK1CYP2D6MYLK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114060-A1 | NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-04-27 | — | — | US | claimed |
| WO-2015187827-A1 | NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-12-10 | — | — | WO | claimed |
| WO-2010029350-A1 | TREATMENT OF FIBROTIC EYE DISORDERS | UNIVERSITY OF EAST ANGLIA (GB) | 2010-03-18 | — | — | WO | claimed |
| US-7452877-B2 | Methods for treating digestive functional pathologies | RYTEK (FR) | 2008-11-18 | — | — | US | claimed |
| US-12544371-B2 | Methods and compositions for treating acute lung injury and acute respiratory distress syndrome | CALCIMEDICA, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| US-12533359-B2 | Method for preventing hair loss | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250120969-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION INJURY IN THE LUNGS | AVENUE CAPITAL MANAGEMENT II, L.P. | 2025-04-17 | — | — | US | disclosed |
| CN-118871110-A | Methods and compositions for treating inflammatory lesions of the lung | 钙医学公司 | 2024-10-29 | — | — | CN | disclosed |
| US-20240352418-A1 | METHOD FOR PRODUCING MULTINUCLEATED MEGAKARYOCYTE WITH ENHANCED PLATELET PRODUCTION CAPABILITY, METHOD FOR PRODUCING PLATELETS, METHOD FOR PRODUCING PLATELET PREPARATION, AND METHOD FOR PRODUCING BLOOD PREPARATION | MEGAKARYON CORPORATION (JP) | 2024-10-24 | — | — | US | disclosed |
| US-20240207270-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM | WAVEBREAK INC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207270-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM | WAVEBREAK INC (US) | 2024-06-27 | — | — | US | disclosed |
| EP-4342982-A1 | METHOD FOR PRODUCING MULTINUCLEATED MEGAKARYOCYTE WITH ENHANCED PLATELET PRODUCTION CAPABILITY, METHOD FOR PRODUCING PLATELETS, METHOD FOR PRODUCING PLATELET PREPARATION, AND METHOD FOR PRODUCING BLOOD PREPARATION | Megakaryon Corporation (JP) | 2024-03-27 | — | — | EP | disclosed |
| WO-2010029350-A1 | TREATMENT OF FIBROTIC EYE DISORDERS | UNIVERSITY OF EAST ANGLIA (GB) | 2010-03-18 | — | — | WO | disclosed |
| US-20080096238-A1 | HIGH THROUGHPUT ASSAY FOR HUMAN RHO KINASE ACTIVITY WITH ENHANCED SIGNAL-TO-NOISE RATIO | ALCON, INC. (CH) | 2008-04-24 | — | — | US | disclosed |
| US-20080096238-A1 | HIGH THROUGHPUT ASSAY FOR HUMAN RHO KINASE ACTIVITY WITH ENHANCED SIGNAL-TO-NOISE RATIO | ALCON, INC. (CH) | 2008-04-24 | — | — | US | disclosed |
| US-20060194769-A1 | Small molecules that reduce fungal growth | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-31 | — | — | US | disclosed |
| WO-2006081327-A2 | SMALL MOLECULES THAT REDUCE FUNGAL GROWTH | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-03 | — | — | WO | disclosed |
| WO-2006081327-A2 | SMALL MOLECULES THAT REDUCE FUNGAL GROWTH | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-03 | — | — | WO | disclosed |
| US-20060079573-A1 | Methods and compositions for preventing vasospasm | EMORY UNIVERSITY | 2006-04-13 | — | — | US | disclosed |
| US-6399107-B1 | GLYCOSAMINOGLYCAN(GAG); TOPICALLY ADMINISTERING GENISTEIN SODIUM METAVANADATE AND/OR STAUROSPORINE PRIOR TO, DURING OR AFTER LASER SURGERY TO PREVENT CORNEAL CLOUDING | ALCON LABORATORIES, INC. | 2002-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194769-A1 | Small molecules that reduce fungal growth | ERG28, DPM1, CYP51A1 | CYP3A4 3610/4885KMT2A 3817/4885MAPK1 1854/4885 |
| US-12544371-B2 | Methods and compositions for treating acute lung injury and acute respiratory distress syndrome | ORAI1, MAVS, CASR | CYP3A4 4735/4885KMT2A 4829/4885MAPK1 592/4885 |
| US-12533359-B2 | Method for preventing hair loss | MYLK, MYLK3, MYLK2 | CYP3A4 1847/4885KMT2A 1769/4885MAPK1 1319/4885 |
| US-20250120969-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION INJURY IN THE LUNGS | IL1B, MAVS, MMP8 | CYP3A4 4815/4885KMT2A 4725/4885MAPK1 1573/4885 |
| US-20240207270-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM | CPT2, PC, SREBF2 | CYP3A4 2670/4885KMT2A 4386/4885MAPK1 2570/4885 |
| US-20170114060-A1 | NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME | ZC3HAV1, MAVS, EIF2AK2 | CYP3A4 4167/4885KMT2A 2451/4885MAPK1 3467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.